Come up with a name for your new list and we'll add to it:
Vedantra Pharmaceuticals raised a round of funding on July 31, 2012. Investors include
Access BridgeGap Ventures.
Vendantra Pharmaceuticals aims to improve immunotherapy outcomes by enhancing adaptive immune responses. Vedantra's platform technologies are able to deliver agents directly to the antigen-presenting …